ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute on chronic liver failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
4,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
5,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
6,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
7,1,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
8,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
8,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9,1,Laboratory test interference,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
10,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
12,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
13,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
15,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
16,1,Pyoderma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
17,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
18,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
18,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,3,Spontaneous bacterial peritonitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
18,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
21,1,Mononeuropathy,Mononeuropathies,Peripheral neuropathies,Nerv,N
22,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
23,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
23,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
23,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
23,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
24,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
26,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
27,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
28,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
28,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
29,1,Gilbert's syndrome,Inborn errors of bilirubin metabolism,Metabolic and nutritional disorders congenital,Cong,N
29,2,Jaundice acholuric,Haemolyses NEC,Haemolyses and related conditions,Blood,N
30,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
30,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
33,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
33,2,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
33,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
34,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
34,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
35,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
36,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
38,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
39,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
39,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
39,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
39,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
39,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
40,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
40,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
41,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
42,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
42,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
43,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
44,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
44,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
44,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
44,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
44,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
44,6,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
45,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
47,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
48,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
48,2,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
48,3,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
48,4,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
49,1,Cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
50,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
50,3,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
51,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
51,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
53,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
54,1,Chronic pigmented purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
54,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
54,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
56,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
56,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
56,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
56,4,Lymphangitis,Vascular infections,Infections - pathogen unspecified,Infec,N
56,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
57,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
58,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
59,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
60,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
61,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
62,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
62,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
63,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
64,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
65,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
66,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
67,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
67,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
68,2,Migraine without aura,Migraine headaches,Headaches,Nerv,N
68,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
70,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
70,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
71,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
71,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
72,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
72,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
72,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
73,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
73,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
73,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
73,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
74,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
75,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
75,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
75,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
75,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
76,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
76,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
77,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
77,3,Headache,Headaches NEC,Headaches,Nerv,N
77,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
78,1,Primary hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
79,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
79,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
79,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
80,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
81,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
82,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
82,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
85,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
86,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
87,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
87,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
88,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
88,2,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
89,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
90,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
92,1,Anal squamous cell carcinoma,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
92,2,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
92,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
92,4,Bone marrow infiltration,Haematological disorders,Haematological disorders NEC,Blood,N
92,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
92,6,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
92,7,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
92,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
93,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
93,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
94,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
95,1,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
96,1,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
97,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
98,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
99,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
100,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
100,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
100,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
101,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
102,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
102,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
102,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
102,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
102,5,Headache,Headaches NEC,Headaches,Nerv,N
102,6,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
102,7,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
102,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
103,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
103,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
104,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
104,2,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
104,3,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
105,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
105,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
106,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
108,1,Headache,Headaches NEC,Headaches,Nerv,N
108,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
109,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
109,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
110,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
111,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
112,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
112,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
112,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
113,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
114,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
114,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
114,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
114,5,Impatience,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
115,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
116,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
116,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
116,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
116,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
116,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
116,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
117,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
117,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
118,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
119,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
119,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
120,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
120,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
121,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
122,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,1,Disease complication,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
123,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
124,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
124,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
125,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
125,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
126,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
127,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
128,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
129,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
129,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
130,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
130,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
131,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
131,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
132,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,1,Corrected transposition of great vessels,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
134,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
135,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
135,2,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
135,3,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
136,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
136,2,Headache,Headaches NEC,Headaches,Nerv,N
137,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
137,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
137,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
138,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
138,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
138,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
138,4,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
138,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
138,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
139,1,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
140,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
143,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
143,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
143,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
144,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
144,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
146,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
146,4,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
146,5,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
147,1,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
147,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
147,3,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
147,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
148,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
149,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
150,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
150,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
150,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
151,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
152,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
152,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
152,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
152,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
152,5,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
153,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
154,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
154,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
154,5,Headache,Headaches NEC,Headaches,Nerv,N
154,6,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
155,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
156,1,Headache,Headaches NEC,Headaches,Nerv,N
156,2,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
156,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
156,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
156,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
158,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
159,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
160,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
161,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
162,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
162,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
163,2,Headache,Headaches NEC,Headaches,Nerv,N
163,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
163,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
165,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
165,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
166,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
166,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
166,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
166,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
167,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
167,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
168,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
168,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
170,1,Tension headache,Headaches NEC,Headaches,Nerv,N
171,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
172,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
172,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
173,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
175,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
176,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
176,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
177,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
177,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
177,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
177,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
177,5,Deafness,Hearing losses,Hearing disorders,Ear,N
177,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
177,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
177,8,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
177,9,Dissociation,Dissociative states,Dissociative disorders,Psych,N
177,10,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
177,11,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
177,12,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
177,13,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
177,14,Headache,Headaches NEC,Headaches,Nerv,N
177,15,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
177,16,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
177,17,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
177,18,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
177,19,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
177,20,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
177,21,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
177,22,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
177,23,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
178,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
178,2,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
178,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
178,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
179,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
179,2,Tongue exfoliation,Tongue signs and symptoms,Tongue conditions,Gastr,N
180,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
180,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
182,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
183,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
184,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
185,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
185,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
186,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
187,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
187,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
188,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
189,1,Headache,Headaches NEC,Headaches,Nerv,N
189,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
190,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
190,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,1,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
191,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
192,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
193,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,1,Hodgkin's disease stage IV,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
196,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
196,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
197,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
198,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
198,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
199,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
199,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
199,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
199,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
201,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
201,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
202,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
203,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
203,2,Headache,Headaches NEC,Headaches,Nerv,N
203,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
203,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
204,1,Migraine,Migraine headaches,Headaches,Nerv,N
205,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
205,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
205,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
206,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
206,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
206,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
207,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
207,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
207,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
207,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
209,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
209,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
209,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
209,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
210,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
211,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
211,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
211,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
212,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
214,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
214,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
214,4,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
214,5,Physical assault,Criminal activity,Legal issues,SocCi,N
215,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
216,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
217,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
219,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
219,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
220,1,Blood iron increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
221,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
222,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
222,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
223,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
224,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
224,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
